---
title: "Entyvio (vedolizumab), all indications: Drug interactions questions"
description: "Drug interactions questions on Entyvio (vedolizumab) that apply to every indication, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Questions: What drug interactions does Entyvio have? 1 question quoted from 1 source."
canonical: "https://www.evicenter.com/medical-information/entyvio/drug-interactions"
published: "2026-11-14T01:54:55-05:00"
modified: "2026-11-14T01:54:55-05:00"
---

# Entyvio (vedolizumab), all indications: Drug interactions questions

Manufacturer: Takeda Pharmaceuticals U.S.A., Inc.  
Prescribing information: [Entyvio](https://content.takeda.com/?contenttype=PI&product=ENTY&language=ENG&country=USA&documentnumber=1)  
Indication pages: [Ulcerative colitis](https://www.evicenter.com/medical-information/entyvio--ulcerative-colitis)

## Drug interactions

<a id="entyvio-drug-interactions"></a>

### What drug interactions does Entyvio have?

> “Because of the potential for increased risk of PML and other infections, avoid the concomitant 
> use of ENTYVIO with natalizumab products.
> 7.2	
> TNF Blockers
> Because of the potential for increased risk of infections, avoid the concomitant use of 
> ENTYVIO with TNF blockers.
> 7.3	
> CYP450 Substrates
> The formation of CYP450 enzymes may be suppressed by increased levels of certain 
> cytokines (e.g., IL-6, IL-10, TNFα, IFN) during chronic inflammation. Therefore, use of 
> ENTYVIO may normalize the formation of CYP450 enzymes by modulating the underlying 
> disease. Upon initiation or discontinuation of ENTYVIO in patients treated with CYP450 
> substrates, monitor drug concentrations or other therapeutic parameters, and adjust 
> the dosage of the CYP substrate as needed. See the prescribing information of specific 
> CYP substrates.”

Source: [ENTYVIO: Prescribing information, page 4, captured 2026-11-13](https://content.takeda.com/?contenttype=PI&product=ENTY&language=ENG&country=USA&documentnumber=1#page=4)

## Related pages
- [Medical information: Entyvio (vedolizumab): All indications](https://www.evicenter.com/medical-information/entyvio)
- [Indication](https://www.evicenter.com/medical-information/entyvio/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/entyvio/pharmacology)
- [Safety](https://www.evicenter.com/medical-information/entyvio/safety)
- [Specific populations](https://www.evicenter.com/medical-information/entyvio/specific-populations)
- [Storage and supply](https://www.evicenter.com/medical-information/entyvio/storage-and-supply)
- [Access and coverage](https://www.evicenter.com/medical-information/entyvio/access-and-coverage)
